{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "C",
          "alt": "G",
          "position": "289"
        },
        "variant_string_id": "PARK2 C289G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkin is implicated in the formation of Lewy bodies and functions as a ubiquitin-protein ligase. Mutations in PARK2 are linked to autosomal recessive juvenile onset Parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines Parkin's role in Parkinson's disease, including its function in mitophagy and the formation of Lewy bodies."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses functional assays to assess Parkin's ability to redistribute to damaged mitochondria and induce mitophagy.",
          "judgment": "Yes",
          "reasoning": "The assays directly evaluate Parkin's function in mitophagy, which is central to its role in Parkinson's disease."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study compares the mutant Parkin(C289G) to wild-type Parkin and evaluates its ability to induce mitophagy.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type Parkin) are used, but there is no explicit mention of multiple replicates or variant controls."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The mutant Parkin(C289G) fails to redistribute to damaged mitochondria and cannot induce mitophagy, but these effects are rescued by molecular chaperones.",
          "judgment": "Yes",
          "reasoning": "The functional data directly demonstrate that the C289G mutation impairs Parkin's function in mitophagy."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The Parkin(C289G) mutant demonstrates reduced ability to redistribute to damaged mitochondria and induce mitophagy, which is a critical function of Parkin in preventing neurodegeneration. The rescue of these functions by molecular chaperones further supports the functional relevance of this mutation in Parkinson's disease."
    }
  ]
}